Document Detail


Peptide-Functionalized Gold Nanorods Increase Liver Injury in Hepatitis.
MedLine Citation:
PMID:  22994679     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Targeted nanomedicine holds enormous potential for advanced diagnostics and therapy. Although it is known that nanoparticles accumulate in liver in vivo, the impact of cell-targeting particles on the liver, especially in disease conditions, is largely obscure. We had previously demonstrated that peptide-conjugated nanoparticles differentially impact macrophage activation in vitro. We thus comprehensively studied the distribution of gold nanorods (AuNR) in mice in vivo, assessed their hepatotoxicity and impact on systemic and hepatic immune cells, both in healthy animals and experimental liver disease models. Gold nanorods were stabilized with either cetyl-trimethylammoniumbromide (CTAB) or poly (ethylene glycol) (PEG) and additional bioactive tripeptides RGD or GLF. Gold nanorods mostly accumulated in liver upon systemic injection in mice, as evidenced by inductively coupled plasma mass spectrometry (ICP-MS) from different organs and by non-invasive micro-computerized tomography whole-body imaging. In liver, AuNR were only found in macrophages by seedless deposition and electron microscopy. In healthy animals, AuNR did not cause significant hepatotoxicity as evidenced by biochemical and histological analyses, even at high AuNR doses. However, flow cytometry and gene expression studies revealed that AuNR polarized hepatic macrophages, even at low doses, dependent on the respective peptide sequence, towards M1 or M2 activation. While peptide-modified AuNR did not influence liver scarring, termed fibrosis, in chronic hepatic injury models, AuNR-induced preactivation of hepatic macrophages significantly exacerbated liver damage and disease activity in experimental immune-mediated hepatitis in mice. Bioactively targeted gold nanoparticles are thus potentially harmful in clinically relevant settings of liver injury, as they can aggravate hepatitis severity.
Authors:
Matthias Bartneck; Thomas Ritz; Heidrun A Keul; Mona Wambach; Jörg Bornemann; Uwe Gbureck; Josef Ehling; Twan Lammers; Felix Heymann; Nikolaus Gassler; Tom Luedde; Christian Trautwein; Juergen Groll; Frank Tacke
Related Documents :
24058589 - The hierarchical process of differentiation of long-lived antibody-secreting cells is d...
24738849 - Immune-regulation and anti-inflammatory effects of isogarcinol extracted from garcinia ...
23147039 - Alveolar epithelial cells are critical in protection of the respiratory tract by secret...
24711459 - Small molecule-directed immunotherapy against recurrent infection by mycobacterium tube...
24676489 - Perspectives on the therapeutic modulation of an alternative cell death, programmed nec...
24953459 - In acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune...
20443209 - Inhibitory effect of jeju endemic seaweeds on the production of pro-inflammatory mediat...
16314919 - Glucocorticoids in t cell apoptosis and function.
18407359 - Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-21
Journal Detail:
Title:  ACS nano     Volume:  -     ISSN:  1936-086X     ISO Abbreviation:  ACS Nano     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101313589     Medline TA:  ACS Nano     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of intradermal radiofrequency combined with autologous platelet-rich plasma in striae diste...
Next Document:  An unusual presentation of gestational thrombocytopenia.